Literature DB >> 2793857

Unesterified fatty acids inhibit the binding of low density lipoproteins to the human fibroblast low density lipoprotein receptor.

B E Bihain1, R J Deckelbaum, F T Yen, A M Gleeson, Y A Carpentier, L D Witte.   

Abstract

Micromolar concentrations of oleate were found to inhibit reversibly the binding of low density lipoprotein (LDL) to the human fibroblast LDL receptor. The decrease in LDL binding caused a parallel reduction of both 125I-LDL uptake and degradation at 37 degrees C. At 4 degrees C, oleate was also found to displace 125I-LDL already bound to the LDL receptor. The effect of oleate was rapid, reaching 70-80% of maximum displacement with 5-10 min of incubation, and was closely correlated to oleate-albumin molar ratios. Partition analysis of unesterified fatty acids between cells and LDL showed that the inhibitory effect of oleate resulted mainly from an interaction of unesterified fatty acids with the cell surface rather than with the LDL particles. Using different unesterified fatty acids and fatty acid analogs, we found that the inhibitory effect was modulated by both the length and the conformation of the monomeric carbon chain and was directly dependent on the presence of a negative charge on the carboxylic group. At 4 degrees C, the inhibitory effect of oleate never exceeded half of maximum binding capacity. This limitation was associated with the ability of oleate to interact only with part of the population of LDL receptors which spontaneously recycles in the absence of ligand, as demonstrated by the fact that oleate did not induce any reduction of LDL binding after cell treatment with monensin in the absence of LDL. Our results indicate that unesterified fatty acids could participate in the control of LDL catabolism in vivo by direct modulation of the ability of LDL receptor to bind LDL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study.

Authors:  D P Cistola; D M Small
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Spontaneous transfer of monoacyl amphiphiles between lipid and protein surfaces.

Authors:  J B Massey; D H Bick; H J Pownall
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

3.  Fatty acid transport across lipid bilayer planar membranes.

Authors:  L G Romano-Fontes; R Curi; C M Peres; A Nishiyama-Naruke; K Brunaldi; F Abdulkader; J Procopio
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

4.  Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.

Authors:  B Bouscarel; H Fromm; S Ceryak; M M Cassidy
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

5.  pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids.

Authors:  F Kamp; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.

Authors:  C H Warden; A Daluiski; X Bu; D A Purcell-Huynh; C De Meester; B H Shieh; D L Puppione; R M Gray; G M Reaven; Y D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

7.  Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding.

Authors:  B Bouscarel; S Ceryak; S J Robins; H Fromm
Journal:  Lipids       Date:  1995-07       Impact factor: 1.880

8.  Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in vitro and on liver lipid homeostasis in mice.

Authors:  Hamed Layeghkhavidaki; Marie-Claire Lanhers; Samina Akbar; Lynn Gregory-Pauron; Thierry Oster; Nathalie Grova; Brice Appenzeller; Jordane Jasniewski; Cyril Feidt; Catherine Corbier; Frances T Yen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.